4th Quarter - Report

AMERICAN MEDICAL ASSOCIATION for AMERICAN MEDICAL ASSOCIATION

Firm
Client
Income
—
Expenses
$3,950,000
Expense method
C: businesses, Internal Revenue Code section 162(e)

What was lobbied

6 issue areas, each in the filer's own words, with who lobbied on it and where.

Labor Issues/Antitrust/Workplace LBR

Health Insurance Industry Competition

LobbyistCovered position, as disclosed
TODD ASKEW —
CYNTHIA A BROWN —
JASON MARINO —
CHASE M THOMAS —
ANDREW WANKUM —

Contacted: Federal Bureau of Investigation (FBI); Commerce, Dept of (DOC); Justice, Dept of (DOJ); Office of Natl Drug Control Policy (NDCP); HOUSE OF REPRESENTATIVES; Federal Trade Commission (FTC); Substance Abuse & Mental Health Services Administration (SAMHSA); Food & Drug Administration (FDA); State, Dept of (DOS); President of the U.S.; Centers For Disease Control & Prevention (CDC); Health & Human Services, Dept of (HHS); SENATE; White House Office; Centers For Medicare and Medicaid Services (CMS); Drug Enforcement Administration (DEA); Veterans Affairs, Dept of (VA); Homeland Security, Dept of (DHS)

Immigration IMM

H.R. 2895, Conrad State 30 and Physician Access Reauthorization Act, all provisions S. 948, Conrad State 30 and Physician Access Reauthorization Act, all provisions Immigration Detainees/DNA-Sample Collection Public Charge Immigrant health insurance coverage Immigration

Contacted: HOUSE OF REPRESENTATIVES; Justice, Dept of (DOJ); Health & Human Services, Dept of (HHS); White House Office; Federal Bureau of Investigation (FBI); Centers For Medicare and Medicaid Services (CMS); Substance Abuse & Mental Health Services Administration (SAMHSA); Centers For Disease Control & Prevention (CDC); Veterans Affairs, Dept of (VA); Homeland Security, Dept of (DHS); President of the U.S.; Drug Enforcement Administration (DEA); Food & Drug Administration (FDA); Commerce, Dept of (DOC); Office of Natl Drug Control Policy (NDCP); State, Dept of (DOS); SENATE; Federal Trade Commission (FTC)

Bills named: H.R. 2895 (116th), S. 948 (116th)

Medicare/Medicaid MMM

H.R. 4932, Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) for Health Act of 2019, all provisions S. 2741, Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) for Health Act of 2019, all provisions H.R. 3414, Opioid Workforce Act of 2019, all provisions S. 2892, Opioid Workforce Act of 2019, all provisions H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act, provisions relating to drug pricing transparency, incorporating value into drug pricing, reducing prior authorization burdens, physician samples H.R. 3107, Improving Seniors' Timely Access to Care Act of 2019, all provisions H.R. 1948, Lymphedema Treatment Act of 2019, all provisions S. 518, Lymphedema Treatment Act of 2019, all provisions H.R. 1570, Removing Barriers to Colorectal Cancer Screening Act of 2019, all provisions S. 668, Removing Barriers to Colorectal Cancer Screening Act of 2019, all provisions H.R. 1329, Medicaid Reentry Act, all provisions S. 2648, Rural ACO Improvement Act, all provisions H.R. 19, Lower Costs, More Cures Act of 2019, all provisions S. 348, Resident Physician Shortage Reduction Act of 2019, all provisions Medicare program: Protecting Access to Medicare Act (PAMA)/lab coding Medicare program: Medicare Care Coordination Improvement Act Medicare program: Protecting and Improving Medicare for our Nations Seniors, Section 5 Medicare program: Appropriate Use Criteria (AUC) G-Codes and modifiers Medicare program: Medicare physician payment update Medicare program: Regulatory relief Medicare program: Medicare for All Medicare program: Stark Law and Anti-Kickback Statute Medicare program: Health IT burdens Medicare program: Merit-based Incentive Payment System (MIPS) Medicare program: Data Privacy Medicare program: Alternative Payment Models (APMs) Medicare program: Accountable Care Organizations (ACOs) Medicare program: Pre-diabetes test coverage Medicare program: Patient Access and Interoperability Medicare program: Prior Authorization Medicare program: Evaluation and Management(E/M) Medicare program: Graduate Medical Education/Cap-Flexibility Medicare program: Pharmacy Benefits Manager (PBM)/Rx drug price transparency Medicare program: Primary Care First/medical oncology, radiation oncology, diabetes prevention Medicare program: Medicare Diabetes Prevention Program Medicare program: Open Payments Medicare program: CMS Provider Compliance & Regulatory Relief Medicare program: PECOS Enrollment/Revalidation Medicare and Medicaid programs: Opioids/medication-assisted treatment Medicare and Medicaid programs: Quality Payment Program Medicare and Medicaid programs: Medicare Access and Chip Reauthorization Act (MACRA) implementation/technical improvements/physician payments Medicaid program: Idaho Medicaid Reform Waiver Medicaid program: Funding and maternal mortality

Contacted: Food & Drug Administration (FDA); Centers For Disease Control & Prevention (CDC); Homeland Security, Dept of (DHS); Office of Natl Drug Control Policy (NDCP); Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); Federal Bureau of Investigation (FBI); Justice, Dept of (DOJ); President of the U.S.; Veterans Affairs, Dept of (VA); Federal Trade Commission (FTC); Drug Enforcement Administration (DEA); White House Office; SENATE; HOUSE OF REPRESENTATIVES; State, Dept of (DOS); Commerce, Dept of (DOC); Substance Abuse & Mental Health Services Administration (SAMHSA)

Bills named: S. 668 (116th), S. 2648 (116th), S. 348 (116th), H.R. 3 (116th), S. 2741 (116th), S. 518 (116th), H.R. 4932 (116th), H.R. 3107 (116th), H.R. 1570 (116th), H.R. 19 (116th), S. 2892 (116th), H.R. 1948 (116th), H.R. 1329 (116th), H.R. 3414 (116th)

Budget/Appropriations BUD

S. 1790, National Defense Authorization Act for Fiscal Year 2020, provisions relating to uniformed medical staff cuts CDC funding for gun violence research, mental health, and suicide prevention

LobbyistCovered position, as disclosed
TODD ASKEW —
CYNTHIA A BROWN —
JASON MARINO —
ANDREW WANKUM —

Contacted: Federal Trade Commission (FTC); HOUSE OF REPRESENTATIVES; Commerce, Dept of (DOC); President of the U.S.; Drug Enforcement Administration (DEA); Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA); Substance Abuse & Mental Health Services Administration (SAMHSA); Veterans Affairs, Dept of (VA); Office of Natl Drug Control Policy (NDCP); Justice, Dept of (DOJ); State, Dept of (DOS); Federal Bureau of Investigation (FBI); White House Office; Health & Human Services, Dept of (HHS); SENATE; Homeland Security, Dept of (DHS); Centers For Disease Control & Prevention (CDC)

Bills named: S. 1790 (116th)

Health Issues HCR

H.R. 3502, Protecting People From Surprise Medical Bills Act, all provisions H.R. 3630, No Surprises Act, all provisions S. 1531, Stopping The Outrageous Practice of Surprise Medical Bills Act of 2019, all provisions H.R. 2328, Community Health Investment, Modernization, and Excellence Act of 2019, all provisions S. 1895, Lower Health Care Costs Act, all provisions H.R. 2279, Safe Step Act, all provisions H.R. 2339, Reversing the Youth Tobacco Epidemic Act of 2019, all provisions H.R. 1503, Orange Book Transparency Act of 2019, all provisions H.R. 1520, Purple Book Continuity Act of 2019, all provisions H.R. 987, Strengthening Health Care and Lowering Prescription Drug Costs Act, all provisions S. 2032, Cannabidiol and Marihuana Research Expansion Act, all provisions 21st Century Cures Act 21st Century Cures 2.0 Affordable Care Act/stabilization Surprise Billing Nomination of Stephen Hahn, MD, as FDA Commissioner AMA Privacy Framework Augmented Intelligence (AI)/Information Blocking and Interoperability Opioids EHR Certification Quality Payment Program burdens Data Privacy 42 CFR Part 2 Nondiscrimination Anti-transgender violence Disaggregation of health outcomes related to Asian American and Pacific Islander (AAPI) Data Flavored e-cigarettes/Vaping Schedule II drugs/Annual production quota reduction Telehealth Drug Pricing/Transparency Drug Compounding Software as a Medical Device (SaMD) Health Disparities Physician economic impact

Contacted: Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA); Federal Bureau of Investigation (FBI); Homeland Security, Dept of (DHS); Substance Abuse & Mental Health Services Administration (SAMHSA); Office of Natl Drug Control Policy (NDCP); Federal Trade Commission (FTC); Veterans Affairs, Dept of (VA); Justice, Dept of (DOJ); White House Office; President of the U.S.; Centers For Disease Control & Prevention (CDC); Drug Enforcement Administration (DEA); HOUSE OF REPRESENTATIVES; SENATE; State, Dept of (DOS); Health & Human Services, Dept of (HHS); Commerce, Dept of (DOC)

Bills named: S. 2032 (116th), H.R. 3502 (116th), H.R. 987 (116th), H.R. 3630 (116th), H.R. 2339 (116th), H.R. 1503 (116th), H.R. 2328 (116th), H.R. 2279 (116th), S. 1531 (116th), S. 1895 (116th), H.R. 1520 (116th)

Veterans VET

Scope of Practice Veterans Choice/Community Care Program Tricare Access

LobbyistCovered position, as disclosed
TODD ASKEW —
CYNTHIA A BROWN —
MARGARET D GARIKES —
JASON ALAN SCULL —

Contacted: White House Office; Centers For Disease Control & Prevention (CDC); President of the U.S.; Commerce, Dept of (DOC); Food & Drug Administration (FDA); Drug Enforcement Administration (DEA); State, Dept of (DOS); Substance Abuse & Mental Health Services Administration (SAMHSA); Homeland Security, Dept of (DHS); Centers For Medicare and Medicaid Services (CMS); Justice, Dept of (DOJ); SENATE; Federal Bureau of Investigation (FBI); Veterans Affairs, Dept of (VA); Office of Natl Drug Control Policy (NDCP); Health & Human Services, Dept of (HHS); Federal Trade Commission (FTC); HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.